Participation bias in a randomised trial of screening for lung cancer

被引:76
作者
Hestbech, Mie Sara [1 ]
Siersma, Volkert [2 ]
Dirksen, Asger [3 ]
Pedersen, Jesper H. [4 ]
Brodersen, John [2 ]
机构
[1] Univ Copenhagen, Dept Gen Practice, DK-1014 Copenhagen, Denmark
[2] Univ Copenhagen, Res Unit Gen Practice, DK-1014 Copenhagen, Denmark
[3] Gentofte Univ Hosp, Dept Resp Med, DK-2900 Hellerup, Denmark
[4] Rigshosp, Dept Thorac Surg, DK-2100 Copenhagen, Denmark
关键词
Participation bias; Recruitment; Volunteering; Lung cancer; Mass screening; Screening-effect; Randomised controlled trial; Danish Lung Cancer Screening Trial (DLCST); SPIRAL COMPUTED-TOMOGRAPHY; SELF-SELECTION; NON-ATTENDANCE; HEALTHY-VOLUNTEERS; PHASE-I; PERSONALITY; CT; MAMMOGRAPHY; PREDICTORS; PROGRAM;
D O I
10.1016/j.lungcan.2010.12.018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Participation bias might affect the results and the representability of randomised controlled trials. We investigated the degree of socio-demographic and psychosocial participation bias in the Danish Lung Cancer Screening Trial (DLCST). Methods: In DLCST the questionnaire COS-LC (Consequences of Screening in Lung Cancer) was used to measure the psychosocial aspects of screening. To investigate a difference with a comparable representative sample from the Danish population, we sent out an inclusion questionnaire to 3999 Danes in the age from 50 to 70 years randomly selected from the Central National Register. Those who completed the inclusion questionnaire and met the inclusion criteria from DLCST received the COS-LC. Those who completed the COS-LC-and thus formed a population sample comparable to DLCST - were compared to the DLCST participants on socio-demographics and psychosocial measures. Results: Participation rates were high among the comparable population sample: 75.3% completed the inclusion questionnaire and 77.4% of those who were eligible completed the COS-LC. The analyses revealed differences between the DLCST participants and the comparable population sample in the following socio-demographic aspects: social group, living alone, gender, age and geographical area. DLCST participants reported less negative psychosocial aspects than the comparable population sample. Conclusion: The present study has shown substantial socio-demographic and psychosocial participation bias in DLCST. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:325 / 331
页数:7
相关论文
共 50 条
  • [21] Interstitial lung diseases in a lung cancer screening trial
    Sverzellati, N.
    Guerci, L.
    Randi, G.
    Calabro, E.
    La Vecchia, C.
    Marchiano, A.
    Pesci, A.
    Zompatori, M.
    Pastorino, U.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (02) : 392 - 400
  • [22] Lung Cancer Screening Among Mammography Patients: Knowledge, Eligibility, Participation, and Interest
    Novogrodsky, Eitan
    Haramati, Linda B.
    Villasana-Gomez, Geraldine M.
    Goldman, Jessica
    Rosenfeld, Cyril
    Rosenblum, Jessica K.
    Sayre, James W.
    Hoyt, Anne C.
    Goldin, Jonathan G.
    Milch, Hannah S.
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2023, 36 (04) : 557 - 564
  • [23] Structural distress screening and supportive care for patients with lung cancer on systemic therapy: A randomised controlled trial
    Geerse, O. P.
    Hoekstra-Weebers, J. E. H. M.
    Stokroos, M. H.
    Burgerhof, J. G. M.
    Groen, H. J. M.
    Kerstjens, H. A. M.
    Hiltermann, T. J. N.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : 37 - 45
  • [24] Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial
    van der Aalst, Carlijn Michelle
    van den Bergh, Karien Anna Margaretha
    Willemsen, Marc Christiaan
    de Koning, Henricus Johannes
    van Klaveren, Robertus Johannes
    THORAX, 2010, 65 (07) : 600 - 605
  • [25] Yorkshire Lung Screening Trial (YLST) pathway navigation study: a protocol for a nested randomised controlled trial to evaluate the effect of a pathway navigation intervention on lung cancer screening uptake
    Mcinnerney, Daisy
    Simmonds, Irene
    Hancock, Neil
    Rogerson, Suzanne
    Lindop, Jason
    Gabe, Rhian
    Vulkan, Daniel
    Marshall, Catriona
    Crosbie, Philip A. J.
    Callister, Matthew E. J.
    Quaife, Samantha L.
    BMJ OPEN, 2024, 14 (07): : 1 - 9
  • [26] Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy
    Pastorino, U.
    Silva, M.
    Sestini, S.
    Sabia, F.
    Boeri, M.
    Cantarutti, A.
    Sverzellati, N.
    Sozzi, G.
    Corrao, G.
    Marchiano, A.
    ANNALS OF ONCOLOGY, 2019, 30 (07) : 1162 - 1169
  • [27] Lung Cancer Screening: The European Perspective
    Veronesi, Giulia
    THORACIC SURGERY CLINICS, 2015, 25 (02) : 161 - +
  • [28] Extrapulmonary neoplasms in lung cancer screening
    Godoy, Myrna C. B.
    White, Charles S.
    Erasmus, Jeremy J.
    Wu, Carol C.
    Truong, Mylene T.
    Munden, Reginald F.
    Chiles, Caroline
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (03) : 368 - 375
  • [29] Text-message Reminders in Colorectal Cancer Screening (TRICCS): a randomised controlled trial
    Hirst, Yasemin
    Skrobanski, Hanna
    Kerrison, Robert S.
    Kobayashi, Lindsay C.
    Counsell, Nicholas
    Djedovic, Natasha
    Ruwende, Josephine
    Stewart, Mark
    von Wagner, Christian
    BRITISH JOURNAL OF CANCER, 2017, 116 (11) : 1408 - 1414
  • [30] New Subsolid Pulmonary Nodules in Lung Cancer Screening: The NELSON Trial
    Walter, Joan E.
    Heuvelmans, Marjolein A.
    Yousaf-Khan, Uraujh
    Dorrius, Monique D.
    Thunnissen, Erik
    Schermann, Anna
    Groen, Harry J. M.
    van der Aalst, Carlijn M.
    Nackaerts, Kristiaan
    Vliegenthart, Rozemarijn
    de Koning, Harry J.
    Oudkerk, Matthijs
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : 1410 - 1414